{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:39:41Z","timestamp":1769186381157,"version":"3.49.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s92455","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T20:33:57Z","timestamp":1446582837000},"page":"537","source":"Crossref","is-referenced-by-count":6,"title":["The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis"],"prefix":"10.2147","author":[{"given":"Habip","family":"Gedik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,11]]},"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=27841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:59:30Z","timestamp":1477853970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-expenditures-related-to-the-use-of-antifungal-drugs-in-patients-wi-peer-reviewed-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ceor.s92455","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}